Basics INmune Bio Inc. Common stock IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotechnology Market Cap: $51.04M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.84% Avg Daily Range (30 D): $0.05 | 2.83% Avg Daily Range (90 D): $0.17 | 4.56% Institutional Daily Volume Avg Daily Volume: .28M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): 2.22M Trade Size Avg Trade Size (Sh.): 120 Avg Trade Size (Sh.) (30 D): 162 Avg Trade Size (Sh.) (90 D): 137 Institutional Trades Total Inst.Trades: 26 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $2M Avg Inst. Trade (90 D): $2M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.74M Avg Closing Trade (30 D): $2M Avg Closing Trade (90 D): $2M Avg Closing Volume: 185.19K     News Jul 31, 2025 @ 11:00 AM INmune Bio Inc. to Report Second Quarter 2025 Fina... Source: Inmune Bio Inc. Jun 26, 2025 @ 8:00 PM INmune Bio Inc. to Announce Top Line Results from ... Source: Inmune Bio Inc. Jul 19, 2024 @ 9:53 PM Inmune Bio re-elects directors, ratifies auditor -... Source: Natashya Angelica Jul 12, 2024 @ 11:37 AM Zura Bio initiates exchange offer for warrants By ... Source: Ismeta Mujdragic May 30, 2024 @ 12:00 PM INmune Bio Inc. to Join Russell 3000® Index Source: INmune Bio, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.49 $-1.05 $-.43 Diluted EPS $-2.49 $-1.05 $-.43 Revenue $ .05M $ M $ .05M Gross Profit $ $ $ Net Income / Loss $ -55.51M $ -24.46M $ -9.74M Operating Income / Loss $ -56.23M $ -24.57M $ -9.91M Cost of Revenue $ $ $ Net Cash Flow $ 12.31M $ 12.42M $ .04M PE Ratio